-
1
EGM enables mapping of DNA-damaging endonuclease activity.
-
2
Study focuses on human LINE-1 retrotransposon as a genetic factor in diseases.
-
3
Provides high-resolution detection of structural variants (SVs).
-
4
Fast operational rate of 1 million base pairs per second.
-
5
Facilitates discoveries in cancer and neurodegenerative diseases.
-
6
Future applications include genome-scale DNA modification analysis.
-
7
Potential to enhance targeted therapies based on specific SVs.
Original Source(s)
Related Content
Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds
Combining a visual inspection of the bladder—systematic endoscopic evaluation—with a blood test to check for the presence of ctDNA may accurately predict which patients with bladder cancer still have ...
April 10, 2026
-
3 min
Frontline Pharma: Tao Chen
A new series championing scientists in the pharmaceutical industry begins with Genentech’s rising star
April 10, 2026
-
8 min
How AI Is Already Having a Significant Impact on Cancer Care
Three education sessions presented during the 2025 ASCO Annual Meeting showcased how artificial intelligence (AI) is quickly transforming cancer care from clinical trial planning and ambient scribes t...
by Jo Cavallo
April 10, 2026
-
10 min
